|
US3854480A
(en)
|
1969-04-01 |
1974-12-17 |
Alza Corp |
Drug-delivery system
|
|
US4675189A
(en)
|
1980-11-18 |
1987-06-23 |
Syntex (U.S.A.) Inc. |
Microencapsulation of water soluble active polypeptides
|
|
EP0073856A1
(en)
*
|
1981-08-28 |
1983-03-16 |
Gist-Brocades N.V. |
Infectious-bronchitis vaccines for poultry, combined infectious-bronchitis vaccines, process for preparing such vaccines, process for preventing infectious bronchitis and infectious-bronchitis virus strain
|
|
US4436727A
(en)
|
1982-05-26 |
1984-03-13 |
Ribi Immunochem Research, Inc. |
Refined detoxified endotoxin product
|
|
US4452775A
(en)
|
1982-12-03 |
1984-06-05 |
Syntex (U.S.A.) Inc. |
Cholesterol matrix delivery system for sustained release of macromolecules
|
|
NL8301996A
(nl)
*
|
1983-06-06 |
1985-01-02 |
Duphar Int Res |
Werkwijze ter bereiding van geadjuveerde levende vaccins en aldus verkregen geadjuveerde levende vaccins.
|
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
|
US5075109A
(en)
|
1986-10-24 |
1991-12-24 |
Southern Research Institute |
Method of potentiating an immune response
|
|
CA1331443C
(en)
|
1987-05-29 |
1994-08-16 |
Charlotte A. Kensil |
Saponin adjuvant
|
|
US5057540A
(en)
*
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
US4895452A
(en)
*
|
1988-03-03 |
1990-01-23 |
Micro-Pak, Inc. |
Method and apparatus for producing lipid vesicles
|
|
US5133974A
(en)
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
|
US5103497A
(en)
|
1989-11-14 |
1992-04-07 |
Hicks John W |
Flying spot endoscope
|
|
EP0468520A3
(en)
|
1990-07-27 |
1992-07-01 |
Mitsui Toatsu Chemicals, Inc. |
Immunostimulatory remedies containing palindromic dna sequences
|
|
US5389369A
(en)
|
1991-02-21 |
1995-02-14 |
Exoxemis, Inc. |
Halo peroxidase containing compositions for killing yeast and sporular microorganisms
|
|
JP3507486B2
(ja)
|
1991-03-15 |
2004-03-15 |
アムジエン・インコーポレーテツド |
顆粒球コロニー刺激因子の肺内投与
|
|
IL101715A
(en)
|
1991-05-02 |
2005-06-19 |
Amgen Inc |
Recombinant dna-derived cholera toxin subunit analogs
|
|
IT1247472B
(it)
|
1991-05-31 |
1994-12-17 |
Fidia Spa |
Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
|
|
ATE175997T1
(de)
|
1991-08-10 |
1999-02-15 |
Medical Res Council |
Behandlung von zellpopulationen
|
|
ES2136092T3
(es)
|
1991-09-23 |
1999-11-16 |
Medical Res Council |
Procedimientos para la produccion de anticuerpos humanizados.
|
|
US6350784B1
(en)
*
|
1996-02-12 |
2002-02-26 |
Meryl J. Squires |
Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases
|
|
US5407686A
(en)
|
1991-11-27 |
1995-04-18 |
Sidmak Laboratories, Inc. |
Sustained release composition for oral administration of active ingredient
|
|
JP3723231B2
(ja)
|
1991-12-23 |
2005-12-07 |
ディミナコ アクチェンゲゼルシャフト |
アジュバント
|
|
IT1253009B
(it)
|
1991-12-31 |
1995-07-10 |
Sclavo Ricerca S R L |
Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini
|
|
DE69313134T2
(de)
|
1992-06-25 |
1998-02-26 |
Smithkline Beecham Biolog |
Adjuvantien enthaltende impfstoffzusammensetzung
|
|
ATE199392T1
(de)
|
1992-12-04 |
2001-03-15 |
Medical Res Council |
Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung
|
|
DK17093D0
(da)
*
|
1993-02-15 |
1993-02-15 |
Lyfjathroun H F |
Farmaceutisk praeparat til topisk administrering af antigener og/eller vacciner til pattedyr via slimhinder
|
|
KR100310510B1
(ko)
|
1993-03-23 |
2002-07-04 |
장 스테판느 |
3-0-탈아세틸화모노포스포릴지질a를함유하는백신조성물
|
|
US5951988A
(en)
*
|
1993-03-30 |
1999-09-14 |
University Of Saskatchewan |
Adjuvant formulation with enhanced immunogenic activity, and related compositions and methods
|
|
US5576016A
(en)
*
|
1993-05-18 |
1996-11-19 |
Pharmos Corporation |
Solid fat nanoemulsions as drug delivery vehicles
|
|
US7223410B1
(en)
*
|
1994-08-05 |
2007-05-29 |
Sanofi Pasteur Limited |
Inactivated respiratory syncytial viral vaccines
|
|
US5961970A
(en)
*
|
1993-10-29 |
1999-10-05 |
Pharmos Corporation |
Submicron emulsions as vaccine adjuvants
|
|
PT729473E
(pt)
|
1993-11-17 |
2001-02-28 |
Deutsche Om Arzneimittel Gmbh |
Dissacaridos de glucosamina metodo para a sua preparacao composicao farmaceutica contendo os mesmos e sua utilizacao
|
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
|
US5451569A
(en)
|
1994-04-19 |
1995-09-19 |
Hong Kong University Of Science And Technology R & D Corporation Limited |
Pulmonary drug delivery system
|
|
US5549901A
(en)
|
1994-05-20 |
1996-08-27 |
Novavax, Inc. |
Antimicrobial oil-in-water emulsions
|
|
US5547677A
(en)
|
1994-05-20 |
1996-08-20 |
Novavax, Inc. |
Antimicrobial oil-in-water emulsions
|
|
AU687562B2
(en)
|
1994-05-20 |
1998-02-26 |
Novavax, Inc. |
Antimicrobial oil-in-water emulsions
|
|
AU713040B2
(en)
|
1994-07-15 |
1999-11-18 |
University Of Iowa Research Foundation, The |
Immunomodulatory oligonucleotides
|
|
AUPM873294A0
(en)
|
1994-10-12 |
1994-11-03 |
Csl Limited |
Saponin preparations and use thereof in iscoms
|
|
KR100201352B1
(ko)
*
|
1995-03-16 |
1999-06-15 |
성재갑 |
단일주사 백신 제형
|
|
UA56132C2
(uk)
|
1995-04-25 |
2003-05-15 |
Смітклайн Бічем Байолоджікалс С.А. |
Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
|
|
US5736152A
(en)
|
1995-10-27 |
1998-04-07 |
Atrix Laboratories, Inc. |
Non-polymeric sustained release delivery system
|
|
US5662957A
(en)
*
|
1996-05-03 |
1997-09-02 |
Novavax, Inc. |
Oil containing lipid vesicles with marine applications
|
|
US5700679A
(en)
*
|
1996-06-07 |
1997-12-23 |
Novavax, Inc. |
Lipid vesicles having a bilayer containing a surfactant with anti-viral and spermicidal activity
|
|
ATE234129T1
(de)
|
1996-06-18 |
2003-03-15 |
Alza Corp |
Vorrichtung zur verbesserung der transdermalen verabreichung von medikamenten oder der abnahme von körperflüssigkeiten
|
|
WO1998016247A1
(en)
|
1996-10-11 |
1998-04-23 |
The Regents Of The University Of California |
Immunostimulatory polynucleotide/immunomodulatory molecule conjugates
|
|
US5980898A
(en)
|
1996-11-14 |
1999-11-09 |
The United States Of America As Represented By The U.S. Army Medical Research & Material Command |
Adjuvant for transcutaneous immunization
|
|
KR100453132B1
(ko)
|
1996-12-20 |
2004-10-15 |
앨자 코포레이션 |
경피 약제 플럭스를 향상시키기 위한 장치 및 방법
|
|
US6627198B2
(en)
*
|
1997-03-13 |
2003-09-30 |
Corixa Corporation |
Fusion proteins of Mycobacterium tuberculosis antigens and their uses
|
|
US6491919B2
(en)
*
|
1997-04-01 |
2002-12-10 |
Corixa Corporation |
Aqueous immunologic adjuvant compostions of monophosphoryl lipid A
|
|
US5993412A
(en)
|
1997-05-19 |
1999-11-30 |
Bioject, Inc. |
Injection apparatus
|
|
GB9711990D0
(en)
|
1997-06-11 |
1997-08-06 |
Smithkline Beecham Biolog |
Vaccine
|
|
AU734180B2
(en)
|
1997-08-29 |
2001-06-07 |
Antigenics Llc |
Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient
|
|
EP1279401B1
(en)
|
1997-09-05 |
2008-01-09 |
GlaxoSmithKline Biologicals S.A. |
Oil in water emulsions containing saponins
|
|
GB9718901D0
(en)
|
1997-09-05 |
1997-11-12 |
Smithkline Beecham Biolog |
Vaccine
|
|
CN1285753A
(zh)
|
1997-12-02 |
2001-02-28 |
鲍德杰克特疫苗公司 |
透皮给药微粒疫苗组合物
|
|
US6015832A
(en)
|
1997-12-31 |
2000-01-18 |
The Regents Of The University Of Michigan |
Methods of inactivating bacteria including bacterial spores
|
|
US6814968B1
(en)
*
|
1998-06-04 |
2004-11-09 |
Vanderbilt University |
Inhibition of viral infection and spread with viral and RhoA-derived peptides
|
|
ES2284287T3
(es)
*
|
1998-10-16 |
2007-11-01 |
Glaxosmithkline Biologicals S.A. |
Sistemas adyuvantes y vacunas.
|
|
WO2000050006A2
(en)
*
|
1999-02-26 |
2000-08-31 |
Chiron Corporation |
Microemulsions with adsorbed macromoelecules and microparticles
|
|
EP1154793B1
(en)
|
1999-02-26 |
2010-09-15 |
Novartis Vaccines and Diagnostics, Inc. |
Use of bioadhesives and adjuvants for the mucosal delivery of antigens
|
|
GB9909077D0
(en)
*
|
1999-04-20 |
1999-06-16 |
Smithkline Beecham Biolog |
Novel compositions
|
|
US6506803B1
(en)
|
1999-04-28 |
2003-01-14 |
Regents Of The University Of Michigan |
Methods of preventing and treating microbial infections
|
|
US7767216B2
(en)
*
|
1999-04-28 |
2010-08-03 |
The Regents Of The University Of Michigan |
Antimicrobial compositions and methods of use
|
|
US6635676B2
(en)
*
|
1999-04-28 |
2003-10-21 |
Regents Of The University Of Michigan |
Non-toxic antimicrobial compositions and methods of use
|
|
US6559189B2
(en)
|
1999-04-28 |
2003-05-06 |
Regents Of The University Of Michigan |
Non-toxic antimicrobial compositions and methods of use
|
|
US6558695B2
(en)
*
|
1999-12-16 |
2003-05-06 |
Dermatrends, Inc. |
Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
|
|
DE60013321T2
(de)
*
|
1999-12-30 |
2005-02-17 |
Kimberly-Clark Worldwide, Inc., Neenah |
Antimikrobieller absorbierender artikel und verfahren zu seiner herstellung und verwendung
|
|
US6651655B1
(en)
|
2000-01-18 |
2003-11-25 |
Quadrant Technologies Limited |
Inhaled vaccines
|
|
US20020155084A1
(en)
*
|
2000-06-02 |
2002-10-24 |
The Regents Of The University Of The Michigan |
Nanoemulsion formulations
|
|
US6565873B1
(en)
*
|
2000-10-25 |
2003-05-20 |
Salvona Llc |
Biodegradable bioadhesive controlled release system of nano-particles for oral care products
|
|
EP2545937A1
(en)
*
|
2001-06-05 |
2013-01-16 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
|
KR20050048539A
(ko)
*
|
2001-10-06 |
2005-05-24 |
메리얼엘엘씨 |
ＣｐＧ 제제 및 관련된 방법
|
|
US20050208083A1
(en)
*
|
2003-06-04 |
2005-09-22 |
Nanobio Corporation |
Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
|
|
PL1651265T3
(pl)
*
|
2003-07-24 |
2008-10-31 |
Merial Ltd |
Formulacje szczepionek zawierających emulsję olej w wodzie
|
|
KR20070052273A
(ko)
*
|
2004-06-30 |
2007-05-21 |
아이디 바이오메디컬 코포레이션 오브 퀘벡 |
코로나바이러스 감염의 치료를 위한 백신 조성물
|
|
EP1817416A2
(en)
*
|
2004-11-05 |
2007-08-15 |
Intradigm Corporation |
Compositions for treating respiratory viral infections and their use
|
|
CA2600054A1
(en)
*
|
2005-03-09 |
2006-09-21 |
Combe Incorporated |
Stable mixed emulsions
|
|
JP2009504805A
(ja)
*
|
2005-08-09 |
2009-02-05 |
ナノバイオ コーポレーション |
抗炎症活性を有するナノエマルジョン組成物
|
|
US20070292688A1
(en)
*
|
2005-08-18 |
2007-12-20 |
Eastman Kodak Company |
Silylamine modified nanoparticulate carriers
|
|
US20080039295A1
(en)
*
|
2006-08-14 |
2008-02-14 |
Zeev Steinmetz |
Method and device to enable and assist the elderly and females to exercise their abdominal and lower back muscles
|
|
EP2152304B1
(en)
*
|
2007-05-02 |
2018-08-22 |
The Regents of the University of Michigan |
Nanoemulsion therapeutic compositions and methods of using the same
|
|
EP2293814A4
(en)
*
|
2008-05-23 |
2013-02-13 |
Univ Michigan |
NANOEMULSION AGENTS
|
|
US8877208B2
(en)
*
|
2008-05-23 |
2014-11-04 |
The Regents Of The University Of Michigan |
Multivalent nanoemulsion vaccines
|